Status:
UNKNOWN
Chinese Herb Nephropathy Epidemiology and Association With CYP2D6, CYP2C19, PXR, or MDR1 Polymorphism
Lead Sponsor:
National Taiwan University Hospital
Collaborating Sponsors:
Department of Health, Executive Yuan, R.O.C. (Taiwan)
Conditions:
Kidney Diseases
Eligibility:
All Genders
Brief Summary
1. Chinese herb nephropathy (CHN), a kind of kidney failure caused by Chinese herbs, may be related to the a component called aristolochic acid (AA). 2. AA may form AA-DNA adducts and accumulate in th...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patient with suspected Chinese herb nephropathy, and their family Control group match for sex age and geographic area (with or without herabla use)
Exclusion
Key Trial Info
Start Date :
May 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01503645
Start Date
May 1 2006
Last Update
November 14 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Far Estern Memorial Hospital
Banqiao District, Taipei, Taiwan, 22060
2
National Taiwan University Hospital
Taipei, Taiwan, 10051